Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
BörsenkürzelKVUE
Name des UnternehmensKenvue Inc
IPO-datumMay 04, 2023
CEOPerry (Kirk L)
Anzahl der mitarbeiter22000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 04
Addresse1 Kenvue Way
StadtSUMMIT
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07901
Telefon19088741200
Websitehttps://www.kenvue.com
BörsenkürzelKVUE
IPO-datumMay 04, 2023
CEOPerry (Kirk L)